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1. Introduction 
The glucagon receptor and catalytic unit of 
adenylate cyclase are separate ntities [ 1,2] able to 
undergo free lateral diffusion in the plane of the 
bilayer [3,4]. Upon addition of hormone they 
interact o form a multicomponent system spanning 
the bilayer membrane [3]. 
The activity of the catalytic unit in the absence of 
hormone is only sensitive to those lipid phase separa- 
tions occurring in the inner half of the bilayer, where- 
as in the presence of glucagon, the coupled receptor- 
catalytic unit senses lipid phase separations occurring 
in both bilayer halves [5-71. 
Cholesterol is a major constituent of the lipids of 
the plasma membrane (e.g., see [a]) and it has been 
suggested that the phase separations observed in such 
membranes must occur in relatively cholesterol free 
areas [9] due to its lateral segregation by specific 
lipids [lo]. 
The water soluble polyene antibiotic, amphop- 
tericin B interacts pecifically with cholesterol with 
great avidity [l 11. This study demonstrates it has a 
marked effect on Arrhenius plots of adenylate cyclase 
activity, and it differentially affects the fluoride- and 
glucagon-stimulated activities. 
2. Materials and methods 
Rat liver plasma membranes were prepared and 
stored as in [ 121. 
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Adenylate cyclase was assayed as in [ 121, ensuring 
that linear timecourses were obtained under all 
conditions [5,9,12] and assay pH remained constant. 
Lubrol solubilised adenylate cyclase was prepared as 
in [ 131. Glucagon was a gift from Dr W. W. Bromer, 
Eli Lilly and Co., Indianapolis. Amphoptericin B was 
a kind gift from E. R. Squibb and Sons, Liverpool. 
Creatine phosphate and creatine kinase were from 
Sigma. Cyclic AMP, ATP and triethanolamine-HCl 
were from Boerhinger. Lubrol PX was a gift from 
ICI Ltd, Macclesfleld, Cheshire. All other 
chemicals were of A.R. quality from BDH Chemicals, 
Poole, Dorset . 
3. Results and discussion 
Amphoptericin B progressively inhibited the 
activity of fluoride-stimulated a enylate cyclase to 
-50% of its original activity at 10m6 M (fig.1). In 
contrast he glucagon-stimulated activity was increased 
by some 30% at lo-’ M amphoptericin B. As the 
amphoptericin B concentration was increased this 
activity fell, to reach a plateau of activity similar to 
that of the original (fig.1). These changes in activity 
exhibited no apparent time dependence as assays 
over 10 mm were linear, and preincubation of assays 
(without ATP) on ice for 30 min had no effect on 
their form. These effects could be reversed by exten- 
sive washing of the membranes (X4) with 1 mM 
KHCOs (pH 7.2) to remove bound amphoptericin B. 
Using a Lubrol-solubilised preparation, amphop- 
tericin B had no effect on adenylate cyclase activity 
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Fig.1. The effect of amphoptericin B on adenylate cyclase 
activity. Experiments were carried out at 30°C following 
fluo~d~s~~at~ activity (*) and glucagon-stimu~t~ 
activity (A). Errors are SD using 4 plasma membrane prepara- 
tions. 
or the form of Arrhenius plots of this activity, 
suggesting that the effects observed were due to an 
interaction of the drug at the level of the intact mem- 
brane. That a chemically very different compound, 
filipin, that also interacts efficaciously with cholesterol 
in the membrane, achieves similar effects on the 
glucagon and fluo~de~tim~at~d activities [ 141 would 
support his contention. This being so we examined 
the effects of lo-’ M and 10m6 M amphoptericin B 
on the Arrhenius plots of glucagon- and fluoride. 
stimulated adenylate cyclase. In native plasma mem- 
branes the break at 28°C observed in Arrhenius plots 
of glucagon-stim~ated adenylate cyclase [121 has 
been localised to the external half of the bilayer 
[6,7]. The fluoride-stimulated activity exhibited a 
linear Arrhenius plot, there being no lipid phase 
separation event occurring in the inner half of the 
bilayer over 042°C. 
Figure 2 clearly demonstrates the marked effect 
amphoptericin B has on the Arrhenius plots of both 
activities. At lo-’ M amphoptericin B the Arrhenius 
plots of both stimulated activities exhibited a single 
break at around 20°C (fig.2a). At 10m6 M 
~phopte~c~ B, Arrhenius plots of fluoride- 
stimu~ted activity showed a single break at lO”C, 
whereas those of glucagon-stimulated activity 
exhibited two breaks at around 23°C and 9°C (Iig.2b). 
There is ample evidence that the break at 28’C is 
due to a lipid phase separation occurring in the bilaye t
[6,13,15,16] and this can be m~pulated by incor- 
poration of defined synthetic lecithins into the bilayer 
[S] or by agents increasing bilayer fluidity such as 
the local anaesthetic, benzyl alcohol [13]. 
Amphoptericin B can interact with cholesterol 
with high avidity to form a complex; this complex is 
preferred to that between cholesterol and phospho- 
lipids [ 111. Thus upon addition of amphoptericin B 
to liver plasma membranes, we might well expect o 
see a lateral redistribution of lipid species. Presumably 
those phospholipids which preferentially interacted 
with cholesterol [lo] may be freed to mix with other 
lipids in those relatively cholesterol free areas 
occupied by enzymes. If the physical properties of 
lipids pre~ously ~teract~ng with cholesterol were 
different from those of the lipids in the original 
cholesterol-depleted areas, then we might well expect 
to see changes in the lipid phase separations 
experienced. Upon this model, at 1 0m6 M amphop- 
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Fig.2 Arrhenius plots of adonylate cyclase activity. (a) 
Fluoride-stimulated activity in the presence of 10m9 M 
(a) and lo-‘ M (0) amphoptericin. (b) Glucagon-stimulated 
activity in the presence of 10e9 M (A) and low6 M (A) 
amphoptericin. 
tericin B it is tempting to assign the break at 8-10°C 
seen in Arrhenius plots of fluoride- and glucagon- 
stimulated adenylate cyclase to the inner half of the 
bilayer. The break at 23°C seen only in the plot of 
the glucagon-stimulated enzyme presumably reflects 
that of a lipid phase separation i  the external half 
of the bilayer. This interpretation suggests hen, that 
the effect of amphoptericin B (1 0m6 M) in com- 
plexing cholesterol in the plasma membrane, depresses 
the lipid phase separation at 28°C occurring in the 
outer half of the bilayer by -S”C, and causes the 
appearance of a lipid phase separation at 10°C in the 
inner half of the bilayer. At 10m9 M amphoptericin 
B, the break at 20°C in the fluoride-stimulated 
enzyme presumably reflects the appearance of a lipid 
phase separation i  the inner bilayer half. The 
Arrhenius plot of glucagon stimulated activity exhibits 
but a single break around 21”C, due on this model to 
its sensitivity to the break at 20°C in the inner half of 
the bilayer and also to a lipid phase separation i  the 
outer half of the bilayer which has been depressed 
below 28°C; their proximity yielding an apparent 
single break. 
Based upon this model we would like to suggest 
that cholesterol is an important modulator of lipid 
phase separations in the liver plasma membrane. It is 
unlikely that it achieves this effect directly, as it 
would cause the smearing or abolition of lipid phase 
separations [lo], but rather influences them by inter- 
acting preferentially with certain phospholipid species 
[IO] achieving a lateral lipid segregation i  the bilayer. 
The decrease in break temperature suggests an 
increase in fluidity of the bilayer (at 3O”C), which 
would be expected to increase both stimulated 
Table 1 
Effect of amphoptericin B on Arrhenius plot of adenylate cyclase 
Stimulating 
@and 
Amphoptericin B Break (PC) Activation energy (kJ/mol) 
concentration 
Upper Lower Above upper Below upper Below lower 
break break break 
Glucagon 1O-9 M - 20.8 f 1°C - 40.3 * 8.8 81.5 i 14.3 - 
Glucagon lo-‘ M 23.3 * 2.1”C 8.4 zt 1°C 23.7 f 2.9 76.1 i 12.6 122.2 f 17.9 
Fluoride 1O-9 M - 19.6 * 1“C - 42.8 i 8.8 78.1 f 8 
Fluoride lo-‘ M -10 *2Oc - 61.3 f 12.9 146.6 f 40.2 
Errors are SD of 3 separate determinations 
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adenylate cyclase activities [ 131. That this is only 
observed for the glucagon-stimulated activity suggests 
that the lipid species now able to interact with the 
enzyme, after cholesterol complexing with 
amphoptericin B, caused a progressive inhibition of 
the catalytic unit. Thus fluoride-stimulated activity 
is progressively inhibited, and the activation of 
glucagon-stimulated activity which is presumably due 
to an increase in fluidity of the external half of the 
bilayer is countered by the inhibition of the catalytic 
unit. This would lend further support to the conten- 
tion that the headgroup nature of phospholipids can 
influence adenylate cyclase activity [ 6 ,171. 
Acknowledgements 
I.D. thanks the SRC for a research studentship. 
This work was supported by an MRC grant to M.D.H. 
References 
[l] Giorgio, N. A., Johnson, C. B. and Blecher, M. (1974) 
.I. Biol. Chem. 249,428-435. 
[2] Swislocki, N. A., Johnson, C. B. and Tierney, J. (1977) 
Arch. Biochem. Biophys. 179,157-165. 
[3] Houslay, M. D., EIIory, J. C., Smith, G. A., Hesketh, 
T. R., Stein, J. M., Warren, G. B. and Metcalfe, J. C. 
(1977) Biochim. Biophys. Acta 467,208-219. 
t41 
[51 
[61 
[71 
PI 
191 
[lOI 
1111 
[12] 
1131 
[I41 
[I51 
1161 
1171 
Schramm, M. (1979) Proc. Natl. Acad. Sci. USA 76, 
1174-1178. 
Houslay, M. D., Hesketh, T. R., Smith, G. A., Warren, 
G. B. and MetcaIfe, J. C. (1976) Biochim. Biophys. 
Acta 436,495-504. 
HousIay, M. D., Johansson, A., Smith, G. A., 
Hesketh, T. R., Warren, G. B. and Metcalfe, J. C. (1976) 
Nobel Found. Symp. 34,331-334. 
HousIay, M. D. (1979) Biochem. Sot. Trans. 7,843-846. 
Colbeau, A., Nachbaur, J. and Vignais, P. M. (1971) 
Biochim. Biophys. Acta 249,462-492. 
HousIay, M. D. and Paliner, R. W. (1978) Biochem. 
J. 174,909-919. 
Demel, R. A., Javen, J. W., Van Dijck, P. W. M. and 
Van Deenen, L. L. M. (1977) Biochhn. Biophys. Acta 
465, l-10. 
De Kruijff, B., Gerritsen, W. J., Oerlemans, A., 
Van Dijck, P. W. M., Demel, R. A. and Van Deenen, 
C. C. M. (1974) Biochii. Biophys. Acta 339,44-56. 
HousIay, M. D., MetcaIfe, J. C., Warren, G. B., 
Hesketh, T. R. and Smith, G. A. (1976) Biochim. 
Biophys. Acta 436,489-494. 
Dipple, I. and HousIay, M.D. (1978) Biochem. 3. 
174,179-190. 
Lad, P. M., Preston, S. M., Welton, A. F., Nielsen, T. B. 
and RodbeII, M. (1979) Biochim. Biophys. Acta 551, 
368-381. 
Sauerheber, R. D., Gordon, L. M., CrosIand, R. D. and 
Kuwaha,M. D. (1977) J. Membr. Biol. 31, 131-169. 
Gordon, L. M., Sauerheber, R. D. and Esgate, J. A. 
(1978) J. Supramol. Struct. 9,299-326. 
Engelhard, V. H., Glaser, M. and Storm, D. R. (1978) 
Biochemistry 17,1110-1120. 
24 
